about
Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistanceAssociation of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah.Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyemaIntrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.National hospitalization trends for pediatric pneumonia and associated complicationsIncreasing incidence of empyema complicating childhood community-acquired pneumonia in the United StatesPsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal typePrevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae.Measuring community similarity with phylogenetic networks.Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.Simultaneous identification of 29 prevalent invasive pneumococcal serotypes or pairs of serotypes by hybridization-ligation PCR.A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection.Diagnosis of Upper and Lower Respiratory Tract Bacterial Infections with the Use of Multiplex PCR Assays.Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel.Emergence of parapneumonic empyema in the USA.Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a reviewParapneumonic empyema in children before the era of pneumococcal vaccination.What is different about serotype 1 pneumococci?Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.Parapneumonic Effusion in Children: An Up-to-Date Review.Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007.Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children.Differences Between Radiologically Confirmed Pneumonia With and Without Pleural Fluid in Hospitalized Children Younger Than 5 Years in Southern Israel.Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.Has the incidence of empyema in Scottish children continued to increase beyond 2005?Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression.Direct serogrouping of Streptococcus pneumoniae strains in clinical samples by use of a latex agglutination testSerotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008.Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children.
P2860
Q26851961-945DBE85-B066-4768-A4FC-1ACA9B42A607Q30388317-81405533-4BB9-4BF1-A01E-FEEFA91C8E82Q30498477-BDD76CFC-7098-463C-9CE0-C6727FB890A1Q30532487-84BAFDC1-A4B2-495B-A5ED-93B4A4369734Q33627308-91C70422-FE9B-4550-BE7E-85036C381D90Q33947633-F7A8CE0D-410F-4CAC-9CA8-47BCECDFACBEQ34039927-64DC07B7-AB23-4B69-967C-D1C760F0693CQ34099491-14F499E3-6C61-4C30-B040-8BA6D92F1436Q34289805-28962179-192E-489F-B9F5-7B9395A07640Q34358647-AA1CD8EF-7606-4C52-826A-D3510A141E03Q34390428-77CE4A6A-1855-414B-B3D2-C66CD265A897Q34395856-18D81615-2292-447D-B1E0-95361220E876Q34876231-B1AE4333-C3C3-4A5B-86E2-18397E308E7BQ34933012-A26E679A-3141-4946-9F67-C803E61D286CQ35099768-434642B3-62B7-4DC6-8321-EA7B24754A5DQ35822877-06ED5EC6-6C89-4ED8-BF4A-1AACEA519D2AQ36022999-19DF13B9-C9C1-49AB-9E50-BC9256E76D0EQ36133960-CA4DB08D-2359-4B7D-8B47-EA4E65F0E59EQ36335142-AB42F60F-D4F4-4A1D-A9B3-52C09DE7F71CQ36362996-966F1F7B-E07B-43E0-B6B7-03F106D12D15Q36763044-9F2AD932-BEBC-461C-A3BB-B68BE21A2F4FQ36970232-A0BAD04A-91BB-4BD3-B81C-1D40DFF0430EQ37156951-F41073D9-5900-4AB2-98F8-3A9ECF77D120Q37470328-0F41B82F-2CCC-423D-99DF-2E509419CA8EQ37559623-24FF59B2-C5D0-4C47-81AD-3F1C3FE4B73FQ37622887-4A89A9DF-0088-4895-AA0D-79FDA1618351Q37693513-745C33E4-4B73-4CC3-894D-B737D6074AD2Q37858596-10A2EB1A-482A-4E4C-93B2-B39DA9464BBDQ37970702-4F6C3EED-3C8C-455F-9EFF-C05B1D7A4A12Q38079159-E50D352E-4999-4D83-B0C2-EBD4A2A65662Q38520923-BC11A19C-E73B-440E-A593-31411EA3FA2FQ40254594-133103A8-414A-4EFA-AE33-B85281267EAEQ40722687-A0508792-1CE3-44E3-AF98-6D621FDE0721Q40906103-23515012-C659-4244-994D-D573A2B30AD5Q41715337-7428B8F2-ADDD-4310-B997-CD723EB7CC3FQ41724923-F717C03E-E17E-4256-8D9C-C803BBF1AC94Q41839223-255551A4-3C25-4914-927F-4B02DC65A1C4Q41959232-20903B85-3313-480B-8394-3BA7FB7804C0Q42363637-E46C166A-BAEE-418D-A26A-02B0F7C4FB83Q43890839-E76FDDE0-C11A-4CC7-B64C-F86E90C48BD6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric parapneumonic empyema, Spain.
@en
Pediatric parapneumonic empyema, Spain.
@nl
type
label
Pediatric parapneumonic empyema, Spain.
@en
Pediatric parapneumonic empyema, Spain.
@nl
prefLabel
Pediatric parapneumonic empyema, Spain.
@en
Pediatric parapneumonic empyema, Spain.
@nl
P2093
P2860
P50
P356
P1476
Pediatric parapneumonic empyema, Spain
@en
P2093
Cristina Esteva
David Moreno-Perez
David Sanchez-Tatay
Luis A Arroyo
Sahar S Dhillon
Susanna Hernandez-Bou
William P Hausdorff
P2860
P304
P356
10.3201/EID1409.071094
P577
2008-09-01T00:00:00Z